Poland· PL-100494224

Nolicin

A norfloxacin product containing norfloxacinum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC J01MA06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNolicinATCJ01MA06REGISTER NO.PL-100494224PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Norfloxacin is registered in 11 of 19 countries.

Countries holding a registration under ATC J01MA06 (norfloxacin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Norfloxacin · ATC J01MA06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of norfloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.65 in Italy to $3.00 in Switzerland — a ×4.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Norfloxacin · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.00
  • IT Italy$0.65
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Norfloxacinum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
J01MA06
ATC class
Norfloxacin
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991533830
  • gtin
    05909991533847

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

467 interactions on record for norfloxacin.

Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Norfloxacin · interactions on record

467 records

  • 86 severe
  • 219 moderate
  • 51 minor
  • 42 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PrednisoloneA07EA01severe

69 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Norfloxacin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norfloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Floxacin Stada, Norfloxacin Sandoz
  • Bulgaria · Нолицин
  • Cyprus · Gyrablock, Trizolin
  • Czechia · Gyrablock, Nolicin
  • Germany · Norfloxa, Norfloxacin 1 A Pharma
  • Estonia · Nolicin
  • Spain · Chibroxin, Norfloxacino Cinfa
  • France · Chibroxine, Norfloxacine Biogaran
  • Greece · Fluseminal, Norocin
  • Croatia · Noflox, Nolicin
  • Hungary · Nolicin, Nolicin-S
  • Italy · Naflox, Norfloxacina Abc
  • Lithuania · Nolicin
  • Latvia · Nolicin, Norflox
  • Malta · Norfloxacin Helcor
  • Netherlands · Norfloxacine Cf, Norfloxacine Sandoz
  • Portugal · Chibroxol, Norfloxacina Vitória
  • Romania · Nolicin, Norfloxacin Helcor
  • Slovenia · Nolicin
  • Slovakia · Gyrablock, Nolicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ccda21d-144d-48b8-ad50-a7b9e01b171d
GET /v1/drugs/3ccda21d-144d-48b8-ad50-a7b9e01b171d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909991533830 ¦ Rp ¦ 153542\n10 tabl.\n05909991533847 ¦ Rp ¦ 153543\n20 tabl.",
  "substance": "Norfloxacinum 400 mg",
  "common_name": "Norfloxacinum",
  "pl_product_id": "100494224",
  "pozwolenie_nr": "087/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-03-05"
}

See everything about norfloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.